deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT03858049

Efficacy and Safety of Crinone Versus Combination Medication (ACCESS)

Comparison of Crinone ® Versus Combination Medication for Luteal Phase Support on the Ongoing Pregnancy Rate of Frozen-thawed Cycle in Chinese Population a Randomized, Interventional, Open-label, Phase IV, Single Center, Pilot Study (ACCESS)

Sponsor: Merck KGaA, Darmstadt, Germany

Conditions Infertility
Updated 25 times since 2019 Last updated: Aug 22, 2023 Started: May 31, 2019 Primary completion: Oct 27, 2021 Completion: Oct 27, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The trend in LPS treatment tends to increase the dosage of progesterone in FET-HRT, this study was designed 5 years ago.

A PHASE4 clinical study on Infertility, this trial is terminated or withdrawn. The trial is conducted by Merck KGaA, Darmstadt, Germany and has accumulated 25 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2019 – ~Aug 2019 · 5 months · monthly snapshot~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Dec 2019 · 2 months · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Mar 2020 · 2 months · monthly snapshot~Mar 2020 – ~May 2020 · 2 months · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~Jun 2021 · 2 months · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Nov 2021 · 2 months · monthly snapshot~Nov 2021 – ~Jan 2022 · 2 months · monthly snapshot~Jan 2022 – ~Apr 2024 · 27 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – present · 17 months · monthly snapshot

Change History

25 versions recorded
  1. Feb 2025 — Present [monthly]

    Terminated PHASE4

  2. Sep 2024 — Feb 2025 [monthly]

    Terminated PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  4. Apr 2024 — Jul 2024 [monthly]

    Terminated PHASE4

  5. Jan 2022 — Apr 2024 [monthly]

    Terminated PHASE4

    Status: RecruitingTerminated

Show 20 earlier versions
  1. Nov 2021 — Jan 2022 [monthly]

    Recruiting PHASE4

  2. Sep 2021 — Nov 2021 [monthly]

    Recruiting PHASE4

  3. Jun 2021 — Sep 2021 [monthly]

    Recruiting PHASE4

  4. Apr 2021 — Jun 2021 [monthly]

    Recruiting PHASE4

  5. Mar 2021 — Apr 2021 [monthly]

    Recruiting PHASE4

  6. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE4

  7. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  8. Nov 2020 — Dec 2020 [monthly]

    Recruiting PHASE4

  9. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE4

  10. Sep 2020 — Oct 2020 [monthly]

    Recruiting PHASE4

  11. Aug 2020 — Sep 2020 [monthly]

    Recruiting PHASE4

  12. Jul 2020 — Aug 2020 [monthly]

    Recruiting PHASE4

  13. Jun 2020 — Jul 2020 [monthly]

    Recruiting PHASE4

  14. May 2020 — Jun 2020 [monthly]

    Recruiting PHASE4

  15. Mar 2020 — May 2020 [monthly]

    Recruiting PHASE4

  16. Jan 2020 — Mar 2020 [monthly]

    Recruiting PHASE4

  17. Dec 2019 — Jan 2020 [monthly]

    Recruiting PHASE4

  18. Oct 2019 — Dec 2019 [monthly]

    Recruiting PHASE4

  19. Aug 2019 — Oct 2019 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  20. Mar 2019 — Aug 2019 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Merck KGaA, Darmstadt, Germany
  • Merck Sharp & Dohme LLC
Data source: Merck KGaA, Darmstadt, Germany

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations